A cut-off of >18% CD18+/MCHII−/CD4− cells was used in a proposed algorithm to diagnose AML in dogs with an acute leukemia consisting of >10% or > 1 × 109/L CD34+/MHCII− cells (16). This evidence concerns the gene ITGB2 and acute myeloid leukemia.